← FDA DRUG APPROVALS

FDA ANDA · ANDA040619

METHIMAZOLE

Sponsor: DISCOVERY THERAP

APPLICATION
ANDA040619
TYPE
ANDA
ORIGINAL APPROVAL
2005-07-12
LATEST ACTION
2019-01-18
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

METHIMAZOLEDiscontinued
METHIMAZOLE 15MG · TABLET · ORAL

Approval history

2019-01-18Labeling · Supplement 4 · standardAP
2016-01-15Labeling · Supplement 3 · standardAP
2005-07-12OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →